America's Car-Mart, Inc. (CRMT)
Live price chart, market sentiment, and community perspectives for America's Car-Mart, Inc. (NASDAQ: CRMT).
Live price chart, market sentiment, and community perspectives for America's Car-Mart, Inc. (NASDAQ: CRMT).
On our risk management desk, CRMT's situation is flashing extreme red. The annual report for fiscal 2026 clearly reiterates substantial doubt about the company's ability to continue as a going concern. With lenders having waived broken covenants only through September 7, 2026, and a desperate need to secure a revolving warehouse facility, any slip in third-party cooperation could push this subprime lender straight into restructuring.
As a hedge fund PM looking at the valuation, a price-to-free-cash-flow ratio of 0.5 initially looks like an incredible typo or deep-value anomaly. However, digging into the cash flow statement reveals that the $65.0 million cash inflow exists entirely because the company is shrinking itself to death—writing $122.6 million fewer customer loans and drawing vehicle inventory down by $180.3 million against a massive net loss of $139.1 million.
From a credit and balance sheet analytics perspective, the operational amputation strategy is staggering. Management closed 60 dealerships in fiscal 2026—representing 39% of its active footprint—and cut headcount by 10% just to conserve cash. Sales volumes fell 14.3% to 48,891 units, and net charge-offs climbed to 27.6% of average finance receivables. This is a survival fight, not a growth turnaround.
From a market sentiment standpoint, retail investors reading the headline revenue of $1,281.5 million might miss the forest for the trees. The bottom line shows a net loss attributable to common shareholders of $139.151 million (in thousands), translating to an adjusted loss per share of $3.71, alongside a surging allowance for credit losses hitting 25.15% of receivables.
Watching the debt structure closely, the $300 million rescue loan from Silver Point Capital back in October 2025 completely failed to stabilize the capital structure. The company is stuck in a liquidity crisis where its survival hinges entirely on satisfying milestones under the June 19, 2026 amendment to the Term Loan and extending warehouse facility negotiations that are taking longer than expected.
Explore plasma cleansing, somatic organ swaps, and BCI.